![Tim Coughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/01/2026
Mr. Timothy P.
Coughlin, CPA, is a Chairman at aTyr Pharma, Inc. and an Independent Director at Travere Therapeutics, Inc. He is on the Board of Directors at ADC Therapeutics SA and Travere Therapeutics, Inc. Mr. Coughlin was previously employed as an Independent Director by Fate Therapeutics, Inc., a Vice President-Financial Services by Catholic Health Initiatives, a Vice President-Financial Services by CommonSpirit Health, and a Senior Manager-Health Sciences Practice by Ernst & Young LLP.
He also served on the board at Peloton Therapeutics, Inc. and Neurocrine Biosciences, Inc. He received his undergraduate degree from Temple University (Pennsylvania) and a graduate degree from San Diego State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/10/2025 | 55.500 ( 0,06 % ) | 2 M $ | 31/01/2026 | |
ATYR PHARMA, INC. 0,06 % | 01/05/2025 | 56.000 ( 0,06 % ) | 49 448 $ | 31/01/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director/Miembro de la Junta | 31/03/2015 |
| ATYR PHARMA, INC. | Presidente | 14/03/2024 |
| ADC THERAPEUTICS SA | Director/Miembro de la Junta | 01/06/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director/Miembro de la Junta | 29/05/2025 |
| PELOTON THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/12/2019 |
CommonSpirit Health (Illinois)
 CommonSpirit Health (Illinois) Hospital/Nursing ManagementHealth Services Operates hospitals | Director Financiero/CFO | 01/01/2002 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/01/1999 |
| NEUROCRINE BIOSCIENCES, INC. | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | |
CommonSpirit Health (Illinois)
CommonSpirit Health (Illinois) Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
